Invention Grant
- Patent Title: Flavone derivatives and their preparative method and medical use
- Patent Title (中): 黄酮衍生物及其制备方法和医疗用途
-
Application No.: US13885063Application Date: 2010-11-12
-
Publication No.: US08946457B2Publication Date: 2015-02-03
- Inventor: Hongquan Duan , Nan Qin , Wenyan Niu , Meina Jin , Lihuan Shi , Ying Chen
- Applicant: Hongquan Duan , Nan Qin , Wenyan Niu , Meina Jin , Lihuan Shi , Ying Chen
- Applicant Address: CN Tianjin
- Assignee: Tianjin Medical University
- Current Assignee: Tianjin Medical University
- Current Assignee Address: CN Tianjin
- Agency: Muncy, Geissler, Olds & Lowe, P.C.
- International Application: PCT/CN2010/001818 WO 20101112
- International Announcement: WO2012/061958 WO 20120518
- Main IPC: C07D311/00
- IPC: C07D311/00 ; C07D311/30 ; A61K31/35

Abstract:
Flavone derivatives, preparative method of the derivatives and use thereof as medicaments for treating diabetes. The structure of the derivatives is presented by formula 1: In the structure, R1 and R2, which are identical or not, represent hydrogen atom, halogen, cyano, hydroxyl, trifluoromethyl, thio-methyl, benzyloxy. C1-C8 linear chain or branch chain alkyl, C1-C8 linear chain or branch chain alkoxy. The pharmacological test indicates that the flavone derivatives can significantly increase the glucose consumption of Hep-G2 cell with insulin resistance activity, promote translocation of glucose transporter 4 of skeletal muscle cells (L6GLUT4myc) at different level, and significantly increase glucose intake and utilization by cells. The test proves the fact for the first time that the flavone derivatives can significantly promote translocation of glucose transporter 4 of skeletal muscle cells, and one of the mechanisms for treating diabetes is activating the cell AMPK phosphorylation and phosphorylating the downstream ACC.
Public/Granted literature
- US20130231492A1 FLAVONE DERIVATIVES AND THEIR PREPARATIVE METHOD AND MEDICAL USE Public/Granted day:2013-09-05
Information query